| Document |
Document Title |
|
WO/2024/079733A1 |
The present invention provides a process for the preparation of aminopyridazine derivatives, and novel pyridazine-based and pyrazole-based compounds which are useful as either starting materials or intermediates in said process.
|
|
WO/2024/061804A1 |
The present invention is directed to an electroluminescent device comprising an anode layer, a cathode layer, a first emission layer, a hole injection layer and a first hole transport layer that comprises a compound containing a metal.
|
|
WO/2024/059203A1 |
A ligand L capable of forming a coordinated complex with at least one metal atom, the ligand having a general formula: N(R1R2)-C(R3R4)-C(R5R6)-N(R7)-CH2-C(CR8R9R10)=O. The disclosure describes use of L to form liganded metallic complexes...
|
|
WO/2024/058665A1 |
The invention relates to the field of medicinal chemistry and radiopharmaceuticals, in particular to means, methods and cassettes for the automated synthesis of the radiotracer 6-L-[18F]fluoro-3,4- dihydroxyphenylalanine (6-L-[18F]FDOPA)...
|
|
WO/2024/054920A1 |
A new Li-complexing derivative electrolyte for use in an electrochemical device, method of manufacturing said electrolyte, and an electrochemical device is disclosed. The electrolyte includes a Li-ion complex associated with one or more ...
|
|
WO/2024/048409A1 |
Provided is a composite obtained by bonding, with high strength, a support having a metal part and a metal-organic framework (MOF). The composite comprises a support having a metal part and a metal-organic framework formed on the surfa...
|
|
WO/2024/049306A1 |
This disclosure provides compounds, including chemical conjugates, and compositions comprising these, as well as kits, which are useful in therapeutic and diagnostic procedures, amongst others. This disclosure also provides preparative m...
|
|
WO/2024/046539A1 |
The present invention relates to emitter materials for OLEDs based on defined metal complexes and to their corresponding application in OLEDs.
|
|
WO/2024/045401A1 |
Provided in the present invention are a crystal compound, a preparation method, and the use of same in X-ray direct detection and imaging, relating to the technical field of crystal synthesis. Specifically, the molecular formula of the c...
|
|
WO/2024/038835A1 |
A desulfurizing agent according to the present disclosure removes a sulfur compound from a sulfur compound-containing raw material. The desulfurizing agent is characterized by comprising a metal-organic structure, wherein: the metal-orga...
|
|
WO/2024/038956A1 |
Provided are a compound represented by chemical formula 1, an antireflection film comprising same, and a display device comprising the antireflection film. (wherein substituents in chemical formula 1 are as defined in the specification.)
|
|
WO/2024/038035A2 |
A polymer of structure (A) with two end group R3p and R4p, and a polymer chain (R) which has either repeat units of structures (Ip) or (IIp). R3p, is either a C-1 to C-8 alkyl, a moiety of structure (IIIp), or a moiety of structure (IIIp...
|
|
WO/2024/024818A1 |
[Problem] To provide a simpler method for producing a high-quality metal-organic structure. [Solution] The method for producing a metal-organic structure according to the present invention comprises: providing a stirrer equipped with a...
|
|
WO/2024/019398A1 |
The present invention relates to a method for preparing a metal-organic framework, the method enabling storage capacity of a functional material such as acetylene to be increased. The present invention relates to a method for preparing a...
|
|
WO/2024/015730A2 |
Herein is disclosed amphiphilic small molecules with different hydrophobic and hydrophilic fragments that show high binding affinity to both Aβ plaques and oligomers, and selectively binding Aβ oligomers. These amphiphilic compounds ca...
|
|
WO/2024/015929A2 |
Compositions, methods of synthesis, and methods of use for an imaging agent that preferentially binds to activated VLA4, including, but not limited to a peptide or peptidomimetic ligand radiolabeled for use in PET imaging to identify bon...
|
|
WO/2024/009979A1 |
Provided is a metal-organic structure that has a volume-average particle diameter of 1.0-30.0 μm inclusive and a median diameter ratio of D10 to D90 [D10/D90] of 0.35-1.00 inclusive. This metal-organic structure is appropriately manufac...
|
|
WO/2024/009691A1 |
The present invention provides: a nonaqueous electrolyte solution which comprises (I) at least one compound that is selected from the group consisting of compounds represented by general formula (1), compounds represented by general form...
|
|
WO/2023/249053A1 |
[Problem] To provide a method for producing a film such that during the production of the film, no breakage, tearing or anomalies in external appearance are caused to the film not only at the central part of the film but also at both fix...
|
|
WO/2023/248755A1 |
The present invention provides a material for chemical vapor deposition, a film production method, and a film which are novel. Provided is a material for chemical vapor deposition represented by formula (1). (In the formula, E is an oxyg...
|
|
WO/2023/245215A1 |
The invention relates to a metal-organic framework, comprising [Cu2(Hbtc) 2(bpe)2] . (bpe) and/or [Cu2(Hbtc)2(bpy)2(H2O)2] . (bpy), where bpe represents 1,2-bis(4-pyridyl)ethane, Hbtc represents benzene-1,3,5-tricarboxylic acid and bpy r...
|
|
WO/2023/234187A1 |
The purpose of the present invention is to newly provide a method for producing an organic copper compound that is useful in synthesis of a special amino acid. A method for producing an organic copper compound.
|
|
WO/2023/221249A1 |
A high-efficiency blue light OLED material, a preparation method therefor and an application thereof. The chemical formula of the blue light OLED material is [(Hdma)K(H2ettc)]n, Hdma being dimethylamine cation, and H2ettc being semi-depr...
|
|
WO/2023/215849A2 |
Conductive ink compositions comprising gold complexes are provided. Also provided are methods of preparing the conductive ink compositions, methods of forming conductive structures from the conductive ink compositions, and structures for...
|
|
WO/2023/200346A1 |
A new 1D silver coordination polymer built of the 1,3,5-triaza-7-phosphaadamantane aminophosphine, diclofenac and silver(I) ions is disclosed, the method of preparation and medical use thereof, especially for the treatment of pancreatic ...
|
|
WO/2023/199298A1 |
The present invention relates to poly(melamine-silicate) derivatives as biocidal disinfection and decontamination agents, and to methods for their production and use. More specifically, the invention relates to halogenated adducts of pol...
|
|
WO/2023/192348A1 |
Herein is disclosed a bioinspired approach in which triggered conformational changes are used to control electron transfer (ET) events. Photo-induced conformational rearrangements of a ligand are translated into changes in the coordinati...
|
|
WO/2023/183377A1 |
Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitor compounds and compositions comprising such compounds. The compounds may have a structure according to Formula I (I) Also disclosed are methods o...
|
|
WO/2023/176918A1 |
The purpose of the present invention is to provide a metal-organic framework that exhibits an excellent adsorption performance for adsorption target substances. The present invention is a metal-organic framework that has a decomposition ...
|
|
WO/2023/173626A1 |
Disclosed is a preparation method for an organic silver colloid, comprising: dissolving an inorganic silver salt solid in water to obtain a silver precursor solution; diluting an organic complexing agent by water to obtain an organic com...
|
|
WO/2023/176917A1 |
The purpose of the present invention is to provide an MOF that is capable of quickly adsorbing a target substance in accordance with a change in relative pressure and that exhibits an adsorption amount larger than or equal to a prescribe...
|
|
WO/2023/168686A1 |
The present disclosure provides a compound represented by structural formula (I) : or a pharmaceutically acceptable salt, or a stereoisomer thereof and their use in, e.g. treating a disease or disorder associated with CDK2. This disclosu...
|
|
WO/2023/171305A1 |
An unsaturated hydrocarbon scavenger according to one aspect of the present disclosure has at least one carbon-carbon double bond, and contains a metal-organic framework that has a metal and a ligand coordinated to the metal, wherein the...
|
|
WO/2023/167441A1 |
The present invention relates to a method for producing cesium halide, and more particularly, to: a novel method for producing cesium halide at high purity; and perovskite produced using same.
|
|
WO/2023/164151A1 |
Methods of treating lung cancer in a subject in need thereof are provided, including administering to the subject an effective amount of an imidazolate gold compound according to Formula I, or a pharmaceutically acceptable salt, racemate...
|
|
WO/2023/157982A1 |
The purpose of the present disclosure is to provide a method for isolating a fluorocarbon having one carbon atom. A fluorocarbon isolation method according to the present disclosure comprises isolating a fluorocarbon having n carbon at...
|
|
WO/2023/154724A2 |
The present invention provides novel intermediates and other compounds prepared using compounds of Formula I. These novel compounds include spiroligomers that have particular significance in the peptide industry. The processes described ...
|
|
WO/2023/149636A1 |
A perovskite composite comprising antimony trifluoride, an electronic element comprising same, and a preparation method therefor are disclosed. The perovskite composite comprises tin (Sn)-based perovskite and antimony trifluoride (SbF3) ...
|
|
WO/2023/137672A1 |
L-N-isobutyryl cysteine (L-NIBC) -bound gold cluster Au 18 (L-NIBC) 14, its use for treating multiple sclerosis, Alzheimer's disease (AD), liver cirrhosis, diabetes, Parkinson's disease (PD) or glaucoma, and the use of it for manufacturi...
|
|
WO/2023/136712A1 |
The present invention relates to a dual-mode probe for detecting hydrogen sulfide and a use thereof and, more specifically, to a dual-mode probe that has excellent blood-brain barrier permeability and is capable of fluorescence and nucle...
|
|
WO/2023/118454A1 |
Metal-organic framework material (MOF), comprising at least one metal center and at least one organic compound selected among the compounds according to formula (I): (I) - wherein n is from 1 to 2, - R is –(CH2-CH2-O)m-CH3 with m from ...
|
|
WO/2023/120647A1 |
The purpose of the present invention is to newly provide an organic copper compound useful for the synthesis of a peculiar amino acid. Provided are: an organic copper compound; and a method for producing an organic copper compound.
|
|
WO/2023/092612A1 |
Provided is a two-dimensional coordination polymer based on isocyano coordination and coordinated by carbon atoms and transition metal ions. The types of existing two-dimensional coordination polymers are expanded, and the possibility is...
|
|
WO/2023/093754A1 |
Described herein are two-coordinated d10 metal carbene complexes containing (i) Cu (I), Ag (I), or Au (I), (ii) a pyrazine-fused NHC ligand or a pyridine-fused NHC ligand, and (iii) a carbazole ligand, a pyrido [2, 3-b] indole ligand, or...
|
|
WO/2023/080248A1 |
[Problem] To provide a novel composite or the like in which a metal-organic framework is supported on a metal structure. [Solution] A composite having a metal structure and a metal-organic framework, wherein the metal-organic framework i...
|
|
WO/2023/069767A1 |
This present disclosure is directed to methods for detecting and quantifying radioisotopes ( e.g., radiopharmaceuticals) in a liquid and compositions involving the same. Metal-organic frameworks (MOFs) can be synthesized and used for mea...
|
|
WO/2023/068824A1 |
The present invention provides a novel compound and an organic light-emitting device including same.
|
|
WO/2023/054417A1 |
Provided as an extraction agent capable of selectively extracting lithium salt is a lithium salt extraction agent which is at least one compound selected from the group consisting of compounds represented by general formula (1) and compo...
|
|
WO/2023/041779A1 |
The present invention relates to a metal complex, a semiconductor layer comprising the metal complex and an organic electronic device comprising at least one metal complex thereof.
|
|
WO/2023/041778A2 |
The present invention relates to a compound represented by Formula (I) wherein M is Cu, Zn, Al, Hf; or Formula (V).
|
